Return to Search
EN
Familial Mediterranean Fever (FMF) is primarily a clinical diagnosis, established through a meticulous evaluation of the patient's medical history, physical examination findings, and a set of defined diagnostic criteria.
Key indicators that guide the diagnosis include characteristic recurrent episodes of fever, accompanied by serositis affecting the abdomen, chest, or joints (typically lasting 1-4 days). A significant family history of FMF and a specific ethnic background (e.g., Mediterranean, Middle Eastern) are also strong supporting factors. A positive response to colchicine therapy often further strengthens the diagnostic suspicion.
During an FMF attack, laboratory tests frequently show elevated acute phase reactants, such as an increased white blood cell count, elevated erythrocyte sedimentation rate (ESR), high C-reactive protein (CRP) levels, and increased fibrinogen. These findings reflect the inflammatory process. A crucial diagnostic clue is the rapid normalization of these inflammatory markers between attacks. Other findings, such as microscopic hematuria or proteinuria, may also be observed.
While genetic analysis for MEFV mutations can provide supportive evidence for a clinical diagnosis, it is not a definitive standalone criterion. It's important to note that approximately 10% of patients who meet the clinical diagnostic criteria for FMF may not have any identifiable MEFV mutations.
The diagnostic process often incorporates specific criteria, broadly categorized as follows:
Major Criteria:
* Recurrent febrile attacks with serositis affecting the abdomen, joints (hips, knees, ankles), chest (unilateral pleuritis or pericarditis), scrotum, or skin.
* Isolated fever attacks.
Minor Criteria:
* Less typical presentations of abdominal, joint, or chest pain.
* Exertion-induced leg pain.
* Positive response to colchicine treatment.
* Presence of nephropathic amyloidosis.
Supportive Criteria:
* Family history of FMF.
* Vulnerable ethnic origin.
* Early onset of symptoms (before 20 years of age).
* Severe attacks requiring bed rest.
* Elevated white blood cell count or high acute phase reactants during attacks.
* History of laparotomy or appendectomy with no pathological findings.
* Episodic proteinuria or hematuria.
* Parental consanguinity.
In certain situations, additional investigations like an electrocardiogram (ECG) to assess for pericarditis, synovial fluid analysis to detect sterile inflammatory fluid, or an abdominal computed tomography (CT) scan to exclude other causes of acute abdominal pain, may be employed to aid in the differential diagnosis.
How is Familial Mediterranean Fever Diagnosed?
Key indicators that guide the diagnosis include characteristic recurrent episodes of fever, accompanied by serositis affecting the abdomen, chest, or joints (typically lasting 1-4 days). A significant family history of FMF and a specific ethnic background (e.g., Mediterranean, Middle Eastern) are also strong supporting factors. A positive response to colchicine therapy often further strengthens the diagnostic suspicion.
During an FMF attack, laboratory tests frequently show elevated acute phase reactants, such as an increased white blood cell count, elevated erythrocyte sedimentation rate (ESR), high C-reactive protein (CRP) levels, and increased fibrinogen. These findings reflect the inflammatory process. A crucial diagnostic clue is the rapid normalization of these inflammatory markers between attacks. Other findings, such as microscopic hematuria or proteinuria, may also be observed.
While genetic analysis for MEFV mutations can provide supportive evidence for a clinical diagnosis, it is not a definitive standalone criterion. It's important to note that approximately 10% of patients who meet the clinical diagnostic criteria for FMF may not have any identifiable MEFV mutations.
The diagnostic process often incorporates specific criteria, broadly categorized as follows:
Major Criteria:
* Recurrent febrile attacks with serositis affecting the abdomen, joints (hips, knees, ankles), chest (unilateral pleuritis or pericarditis), scrotum, or skin.
* Isolated fever attacks.
Minor Criteria:
* Less typical presentations of abdominal, joint, or chest pain.
* Exertion-induced leg pain.
* Positive response to colchicine treatment.
* Presence of nephropathic amyloidosis.
Supportive Criteria:
* Family history of FMF.
* Vulnerable ethnic origin.
* Early onset of symptoms (before 20 years of age).
* Severe attacks requiring bed rest.
* Elevated white blood cell count or high acute phase reactants during attacks.
* History of laparotomy or appendectomy with no pathological findings.
* Episodic proteinuria or hematuria.
* Parental consanguinity.
In certain situations, additional investigations like an electrocardiogram (ECG) to assess for pericarditis, synovial fluid analysis to detect sterile inflammatory fluid, or an abdominal computed tomography (CT) scan to exclude other causes of acute abdominal pain, may be employed to aid in the differential diagnosis.